BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 90 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2024. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $221,554 | +428.5% | 43,699 | +192.9% | 0.00% | – |
| Q4 2023 | $41,920 | -64.2% | 14,918 | -35.7% | 0.00% | -100.0% |
| Q2 2023 | $117,211 | +334.1% | 23,210 | +45.3% | 0.00% | – |
| Q3 2022 | $27,000 | -30.8% | 15,973 | +1.1% | 0.00% | – |
| Q2 2022 | $39,000 | +11.4% | 15,804 | +25.8% | 0.00% | – |
| Q1 2022 | $35,000 | -79.7% | 12,560 | -61.0% | 0.00% | -100.0% |
| Q4 2021 | $172,000 | -23.6% | 32,205 | +21.4% | 0.00% | -33.3% |
| Q3 2021 | $225,000 | -80.1% | 26,538 | -71.5% | 0.00% | -76.9% |
| Q2 2021 | $1,133,000 | +128.0% | 92,982 | +353.8% | 0.01% | +116.7% |
| Q1 2021 | $497,000 | -18.7% | 20,489 | +7.5% | 0.01% | -25.0% |
| Q4 2020 | $611,000 | +164.5% | 19,063 | +248.2% | 0.01% | +100.0% |
| Q2 2020 | $231,000 | – | 5,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $5,581,000 | 0.29% |
| NEA Management Company, LLC | 3,449,845 | $9,556,000 | 0.28% |
| Hawkeye Capital Management, LLC | 243,009 | $673,000 | 0.26% |
| DAFNA Capital Management LLC | 313,600 | $869,000 | 0.23% |
| Artal Group S.A. | 1,646,517 | $4,561,000 | 0.19% |
| MPM BioImpact LLC | 239,888 | $664,000 | 0.18% |
| RA Capital Management | 2,589,904 | $7,174,000 | 0.16% |
| Bellevue Group AG | 3,293,000 | $9,122,000 | 0.11% |
| Ikarian Capital, LLC | 159,390 | $441,000 | 0.06% |
| PDT Partners, LLC | 66,168 | $183,000 | 0.02% |